Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
fda
3
×
life sciences
national blog main
biotech
boston blog main
clinical trials
indiana blog main
indiana top stories
national top stories
new york blog main
new york top stories
san francisco blog main
sanofi
startups
abbvie
akili interactive labs
akouos
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
biogen
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
bruce leuchter
calcitonin gene-related peptide
cancer
cancer immunotherapy
cerovene
chronic migraine
click therapeutics
clickotine
covid-19
crispr
david benshoof klein
david klein
What
announced
3
×
medicines
3
×
drug
acquisitions
approval
approved
backs
bets
bio
ceo
class
click
collabs
covid
daniel
deal
decision
developed
digital
eli
example
fda
field
gain
gilead
gilead’s
grabbed
headache
help
introduce
ipo
late
latest
lilly
makers
making
marks
medicine
migraine
momentum
Language
unset
Current search:
fda
×
announced
×
medicines
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum
